Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Lipstatin for preventing untoward reaction after CT enhance examination

A technology for adverse reactions and liprosin, which is applied in the application field of liprastatin in preventing adverse reactions after CT enhanced examination, and can solve the problem that the body's self-healing effect is not sufficient.

Inactive Publication Date: 2017-09-08
付国田
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] At present, for adverse reactions after CT examination, the most commonly used treatment method in Western medicine is to use adrenal hormones and antibiotics for treatment. Although large doses of hormones and antibiotics can effectively relieve symptoms and eliminate adverse reactions, some complications are prone to occur, and for radiation damage The body's self-healing effect is not large

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] This embodiment provides a drug for alleviating adverse reactions after CT-enhanced examination, and the active ingredient is liprestatin. The effective content of the riprestatin is 2%. The stated content is the mass fraction, and the solvent is distilled water.

Embodiment 2

[0019] Example 2 An application example of riprestatin in alleviating adverse reactions after CT-enhanced examination.

[0020] 1. Case selection:

[0021] 200 cases of patients with adverse reactions after enhanced CT scan were selected for clinical observation, and the patients were randomly divided into two groups.

[0022] There were 100 cases in the treatment group and the experimental group, and the average age of the two groups was 30-55 years old. The gender, age, condition, and adverse reaction time of the two groups of patients were compared before treatment, and the difference was not statistically significant and comparable.

[0023] 2. Treatment medication:

[0024] The patients in the experimental group took the liprestatin of Example 1 orally, twice a day, 200ml each time, and took it with warm water one hour before meals, and 2 days was a course of treatment.

[0025] Patients in the control group took warm boiled water and waited for their bodies to relieve ...

Embodiment 3

[0033] Example 3 An application example of riprestatin in preventing adverse reactions after CT-enhanced examination.

[0034] Different from Example 2, this experiment uses 100 volunteers to take the drug of Example 1 of the present invention before the CT-enhanced examination, and observe whether adverse reactions occur after the CT-enhanced examination. The age of the volunteers is between 29-45 years old. It is known through inquiry that they have all undergone CT enhanced examination before and have experienced adverse reactions after the completion.

[0035] The result is as follows:

[0036] Among the 100 volunteers, only 12 patients had mild symptoms of discomfort, and the others had no adverse reactions. These 12 patients continued to take the drug once, and the adverse reactions gradually disappeared within 3 hours.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of liplastatin in preventing adverse reactions after CT-enhanced examination, and at the same time discloses a medicine for alleviating adverse reactions after CT-enhanced examination. The effective content of statins is 0.1‑20%. The present invention discovers and proves for the first time that liprestatin can treat adverse reactions caused by CT, especially hypersensitivity patients who are highly sensitive to contrast agents, and can reduce and relieve their adverse reactions during enhanced scanning. It has been clinically verified that liprestatin has a very significant effect on adverse reactions after CT examination.

Description

technical field [0001] The present invention relates to a new application of liplastatin, in particular to the application of riplastatin in preventing adverse reactions after CT-enhanced examination. Background technique [0002] CT is a full-featured disease detection instrument, which is the abbreviation of computerized X-ray tomography. The scanner used in computed axial tomography (CAT) produces X-rays, a powerful form of electromagnetic energy. X-ray photons are basically the same as photons of ordinary visible light, but they carry more energy. This higher energy level allows X-rays to pass directly through most of the body's soft tissues. Conventional X-ray imaging technology utilizes the principle of light and shadow. A "light" is shone from one side of the body, while film on the other side of the body records the outline of the bones. CT scans take traditional X-ray imaging to a new level. Instead of merely showing the outlines of bones and organs, CT scans c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/365A61P39/02
CPCA61K31/365
Inventor 付国田付小霞陈志波官晓波
Owner 付国田
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com